BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17918252)

  • 1. Soluble TWEAK is markedly elevated in hemophagocytic lymphohistiocytosis.
    Nagasawa M; Yi Z; Imashuku S; Nonoyama S; Ogawa K; Okumura K; Mizutani S
    Am J Hematol; 2008 Mar; 83(3):222-5. PubMed ID: 17918252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children.
    Xu XJ; Tang YM; Song H; Yang SL; Xu WQ; Zhao N; Shi SW; Shen HP; Mao JQ; Zhang LY; Pan BH
    J Pediatr; 2012 Jun; 160(6):984-90.e1. PubMed ID: 22226576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kawada J; Kimura H; Shibata Y; Hara S; Hoshino Y; Kojima S; Nishikawa K; Morishima T
    J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis.
    Tamura K; Kanazawa T; Tsukada S; Kobayashi T; Kawamura M; Morikawa A
    Pediatr Blood Cancer; 2008 Nov; 51(5):662-8. PubMed ID: 18623207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.
    Allen CE; Yu X; Kozinetz CA; McClain KL
    Pediatr Blood Cancer; 2008 Jun; 50(6):1227-35. PubMed ID: 18085676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation?
    Honda K; Ohga S; Takada H; Nomura A; Ohshima K; Kinukawa N; Mizuno Y; Hara T
    Int J Hematol; 2000 Jul; 72(1):55-60. PubMed ID: 10979210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-B-cell colony-enhancing factor is markedly elevated in childhood hemophagocytic lymphohistiocytosis.
    Gao ZY; Li XY; Bhandari V; Li LD; Lan D
    Genet Mol Res; 2015 May; 14(2):5287-95. PubMed ID: 26125724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagoctic lymphohistiocytosis--recent concept.
    Bhattacharyya M; Ghosh MK
    J Assoc Physicians India; 2008 Jun; 56():453-7. PubMed ID: 18822626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TNF-related and weak inducer of apoptosis levels in septic shock patients.
    Nagai M; Hirayama K; Ebihara I; Higuchi T; Imaizumi M; Maruyama H; Miyamoto Y; Kakita T; Ogawa Y; Fujita S; Shimohata H; Kobayashi M
    Ther Apher Dial; 2011 Aug; 15(4):342-8. PubMed ID: 21884467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
    Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
    J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tumor necrosis factor-like weak inducer of apoptosis plasma levels as a novel biomarker of endothelial function in prevalent orthotopic heart transplant recipients.
    Przybylowski P; Malyszko JS; Malyszko J
    Transplant Proc; 2011 Jun; 43(5):1900-3. PubMed ID: 21693297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
    Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
    Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels.
    Xia L; Shen H; Xiao W; Lu J
    Cytokine; 2011 Mar; 53(3):289-91. PubMed ID: 21190865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis.
    Li M; Chen T; Guo Z; Li J; Cao N
    J Dermatol; 2013 Nov; 40(11):891-5. PubMed ID: 23968277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophagocytic lymphohistiocytosis: when the immune system runs amok.
    Janka G
    Klin Padiatr; 2009 Sep; 221(5):278-85. PubMed ID: 19707989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world.
    Switala JR; Hendricks M; Davidson A
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):e89-92. PubMed ID: 22322940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum TWEAK concentration in patients with acute pancreatitis.
    Koçak E; Köklü S; Başar O; Yilmaz FM; Ciftçi A; Kaya C; Cesur S; Demirci S; Akbal E; Taş A
    Scand J Clin Lab Invest; 2012 May; 72(3):192-6. PubMed ID: 22356682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.